抗真菌药物的全球市场，规模，占有率，趋势，产业分析报告:各类药物，各适应症，各剂型，各流通管道，各地区 - 市场预测，2025年～2034年

根据 Polaris Market Research 的最新研究，预计到 2034 年，抗真菌药物市场规模将达到 232.2 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

抗真菌药物市场专注于开发、生产和分销用于治疗各种真菌感染的药物，这些感染会影响皮肤、指甲、黏膜和内臟器官。真菌疾病的发生率不断上升，尤其是在接受癌症治疗、器官移植和患有慢性疾病的免疫功能低下患者中，这推动了对有效抗真菌疗法的稳定需求。

医院内获得性真菌感染的增加迫使医疗保健提供者将抗真菌药物纳入其预防和治疗方案中。行业趋势表明，标靶治疗、改进的药物传输系统以及使用新型製剂来克服抗药性和毒性问题正逐渐成为主流。包括外用、口服和静脉注射的给药平台的持续创新，正在提高患者的依从性和治疗效果。製药公司也正在投资新一代抗真菌药物，以对抗抗药性菌株和侵袭性感染。

不断扩展的诊断能力使早期发现成为可能，有助于改善治疗效果并增加处方量。此外，在目前尚无最佳治疗方法的特定适应症中开发抗真菌药物，以及在服务不足的新兴市场中扩大药物可及性，也存在着发展机会。各公司越来越注重现有药物的生命週期管理，包括药物配方的改良和复方製剂的研发。此外，旨在应对抗菌素抗药性的全球卫生倡议为资金和合作创造了机会，使抗真菌领域成为临床研究的活跃领域。技术和治疗方法的进步，加上对病人安全的日益重视，推动了抗真菌药物市场透过竞争和创新不断发展。

抗霉菌药物市场报告重点

依药物类别划分，唑类药物凭藉其广谱活性和在治疗表浅和全身性真菌感染方面已证实的临床疗效，在2024年占总销售额的48%。

按适应症划分，念珠菌症在2024年占最大的销售额占有率，因为其在免疫功能低下和住院患者中患病率很高。

预计到2024年，北美将占全球抗真菌药物市场收入的约41%，这得益于其先进的医疗基础设施、免疫抑制疗法的频繁使用以及老龄人口的增长。

预计亚太地区将在预测期内实现最高的复合年增长率，因为该地区医疗保健的可及性迅速改善以及人们对真菌感染的认识不断提高。

主要的全球公司包括雅培、安斯泰来製药、拜耳、Enzon Pharmaceuticals、Glenmark、葛兰素史克、默克、诺华、辉瑞和赛诺菲。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 抗真菌药物市场洞察

• 市场概述
• 抗真菌药物市场动态
  • 促进因素和机会
    • 老年人口成长
    • 真菌感染的盛行率
  • 限制与课题
    • 产品成本高
• PESTEL分析
• 抗真菌药物市场力量的评估趋势
• 价值链分析

第5章 抗真菌药物市场:各类药物

• 主要调查结果
• 简介
• Azole
• Echinocandins
• Polyenes
• 丙烯基胺
• 其他

第6章 抗真菌药物市场:各适应症

• 主要调查结果
• 简介
• 皮肤丝状菌症
• 曲菌症
• 念珠菌症
• 其他

第7章 抗真菌药物市场:各剂型

• 主要调查结果
• 简介
• 口服药
• 软膏
• 粉末
• 其他

第8章 抗真菌药物市场:各流通管道

• 主要调查结果
• 简介
• 医院药局
• 零售药局
• 其他

第9章 抗真菌药物市场:各地区

• 主要调查结果
• 简介
  • 抗真菌药物市场分析:各地区，2020～2034年
• 北美
  • 北美:各类药物，2020-2034年
  • 北美:各适应症，2020～2034年
  • 北美:各流通管道，2020～2034年
  • 北美:各剂型，2020～2034年
  • 美国
  • 加拿大
• 欧洲
  • 欧洲:各类药物，2020-2034年
  • 欧洲:各适应症，2020～2034年
  • 欧洲:各流通管道，2020～2034年
  • 欧洲:各剂型，2020～2034年
  • 英国
  • 法国
  • 德国
  • 义大利
  • 西班牙
  • 荷兰
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 亚太地区:各类药物，2020年～2034年
  • 亚太地区:各适应症，2020～2034年
  • 亚太地区:各流通管道，2020～2034年
  • 亚太地区:各剂型，2020～2034年
  • 中国
  • 印度
  • 马来西亚
  • 日本
  • 印尼
  • 韩国
  • 澳洲
  • 其他亚太地区
• 中东·非洲
  • 中东·非洲:各类药物，2020～2034年
  • 中东·非洲:不同症状，2020～2034年
  • 中东·非洲:各流通管道，2020～2034年
  • 中东·非洲:各剂型，2020～2034年
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 以色列
  • 南非
  • 其他中东·非洲
• 南美
  • 南美:各类药物，2020-2034年
  • 南美:各征兆，2020-2034年
  • 南美:各流通管道，2020～2034年
  • 南美:各剂型，2020～2034年
  • 墨西哥
  • 巴西
  • 阿根廷
  • 其他南美国家

第10章 竞争情形

• 扩大和收购的分析
  • 扩大
  • 收购
• 联盟/合作/协定/公开

第11章 企业简介

• Abbott
• Astellas Pharma, Inc.
• Bayer AG
• Enzon Pharmaceuticals, Inc.
• Glenmark
• GSK plc
• Merck & Co., Inc.
• Novartis AG
• Pfizer, Inc
• Sanofi

The antifungal drugs market size is expected to reach USD 23.22 billion by 2034, according to a new study by Polaris Market Research. The report "Antifungal Drugs Market Size, Share, Trend, Industry Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication, By Dosage Form, By Distribution Channel, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The antifungal drugs market focuses on the development, production, and distribution of medications used to treat a wide range of fungal infections affecting the skin, nails, mucous membranes, and internal organs. Rising cases of fungal diseases, particularly among immunocompromised individuals undergoing cancer treatments, organ transplantation, or suffering from chronic illnesses, are driving steady demand for effective antifungal therapies.

The increasing incidence of hospital-acquired fungal infections is pushing healthcare providers to incorporate antifungal agents into preventive and treatment protocols. Industry trends indicate a shift toward the use of targeted therapies, improved drug delivery systems, and novel formulations designed to overcome resistance and toxicity issues. Continuous innovation in topical, oral, and intravenous delivery platforms is enhancing patient adherence and treatment efficacy. Pharmaceutical companies are also investing in new-generation antifungal agents that target resistant strains and invasive infections.

Expanding diagnostic capabilities are enabling early detection, which improves outcomes and fuels prescription volumes. Opportunities lie in developing antifungal solutions for specific indications that currently lack optimal treatments, as well as expanding access in underserved healthcare markets. Companies are increasingly focusing on the lifecycle management of established drugs, including reformulation and fixed-dose combinations. Additionally, global health initiatives aimed at tackling antimicrobial resistance are creating room for funding and partnerships, making the antifungal space an active area for clinical research. The growing emphasis on patient safety, combined with technological and therapeutic advancements, continues to shape a competitive and innovation-driven antifungal drug landscape.

Antifungal Drugs Market Report Highlights

By drug class, the azoles drug segment accounted for ~48% of the revenue share in 2024 due to their broad-spectrum activity and established clinical effectiveness in treating both superficial and systemic fungal infections.

Based on indication, the candidiasis segment held the largest revenue share in 2024 due to its high prevalence among immunocompromised and hospitalized patients.

In 2024, North America accounted for a ~41% share of the global antifungal drugs market revenue due to the strong presence of advanced healthcare infrastructure, frequent use of immunosuppressive therapies, and a growing elderly population.

The market in Asia Pacific is expected to register the highest CAGR during the forecast period due to rapid improvements in healthcare access and growing awareness of fungal infections.

A few global key players include Abbott; Astellas Pharma, Inc.; Bayer AG; Enzon Pharmaceuticals, Inc.; Glenmark; GSK plc; Merck & Co., Inc.; Novartis AG; Pfizer, Inc.; and Sanofi.

Polaris Market Research has segmented the antifungal drugs market report on the basis of drug class, indication, dosage form, distribution channel, and region:

By Drug Class Outlook (Revenue, USD Billion, 2020-2034)

Azoles

Echinocandins

Polyenes

Allylamines

Others

By Indication Outlook (Revenue, USD Billion, 2020-2034)

Dermatophytosis

Aspergillosis

Candidiasis

Others

By Dosage Form Outlook (Revenue, USD Billion, 2020-2034)

Oral Drugs

Ointments

Powders

Others

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacies

Retail Pharmacies

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Antifungal Drugs Market Insights

• 4.1. Antifungal Drugs Market - Market Snapshot
• 4.2. Antifungal Drugs Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Growing Geriatric Population
    • 4.2.1.2. Rising Prevalence of Fungal Infections
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High costs of the products
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Antifungal Drugs Market Power Rating Trends
• 4.6. Value Chain Analysis

5. Antifungal Drugs Market, by Drug Class

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Antifungal Drugs Market, by Drug Class, 2020-2034 (USD Billion)
• 5.3. Azoles
  • 5.3.1. Antifungal Drugs Market, by Azoles, by Region, 2020-2034 (USD Billion)
• 5.4. Echinocandins
  • 5.4.1. Antifungal Drugs Market, by Echinocandins, by Region, 2020-2034 (USD Billion)
• 5.5. Polyenes
  • 5.5.1. Antifungal Drugs Market, by Polyenes, by Region, 2020-2034 (USD Billion)
• 5.6. Allylamines
  • 5.6.1. Antifungal Drugs Market, by Allylamines, by Region, 2020-2034 (USD Billion)
• 5.7. Others
  • 5.7.1. Antifungal Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

6. Antifungal Drugs Market, by Indication

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• 6.3. Dermatophytosis
  • 6.3.1. Antifungal Drugs Market, by Dermatophytosis, by Region, 2020-2034 (USD Billion)
• 6.4. Aspergillosis
  • 6.4.1. Antifungal Drugs Market, by Aspergillosis, by Region, 2020-2034 (USD Billion)
• 6.5. Candidiasis
  • 6.5.1. Antifungal Drugs Market, by Candidiasis, by Region, 2020-2034 (USD Billion)
• 6.6. Others
  • 6.6.1. Antifungal Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

7. Antifungal Drugs Market, by Dosage Form

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• 7.3. Oral Drugs
  • 7.3.1. Antifungal Drugs Market, by Oral Drugs, by Region, 2020-2034 (USD Billion)
• 7.4. Ointments
  • 7.4.1. Antifungal Drugs Market, by Ointments, by Region, 2020-2034 (USD Billion)
• 7.5. Powders
  • 7.5.1. Antifungal Drugs Market, by Powders, by Region, 2020-2034 (USD Billion)
• 7.6. Others
  • 7.6.1. Antifungal Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

8. Antifungal Drugs Market, by Distribution Channel

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• 8.3. Hospital Pharmacies
  • 8.3.1. Antifungal Drugs Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
• 8.4. Retail Pharmacies
  • 8.4.1. Antifungal Drugs Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
• 8.5. Others
  • 8.5.1. Antifungal Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

9. Antifungal Drugs Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Antifungal Drugs Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Antifungal Drugs Market - North America
  • 9.3.1. North America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
  • 9.3.2. North America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
  • 9.3.3. North America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.3.4. North America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.3.5. Antifungal Drugs Market - US
    • 9.3.5.1. US: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.3.5.2. US: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.3.5.3. US: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.3.5.4. US: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.3.6. Antifungal Drugs Market - Canada
    • 9.3.6.1. Canada: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• 9.4. Antifungal Drugs Market - Europe
  • 9.4.1. Europe: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.5. Antifungal Drugs Market - UK
    • 9.4.5.1. UK: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.6. Antifungal Drugs Market - France
    • 9.4.6.1. France: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.7. Antifungal Drugs Market - Germany
    • 9.4.7.1. Germany: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.8. Antifungal Drugs Market - Italy
    • 9.4.8.1. Italy: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.9. Antifungal Drugs Market - Spain
    • 9.4.9.1. Spain: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.10. Antifungal Drugs Market - Netherlands
    • 9.4.10.1. Netherlands: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.11. Antifungal Drugs Market - Russia
    • 9.4.11.1. Russia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.4.12. Antifungal Drugs Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• 9.5. Antifungal Drugs Market - Asia Pacific
  • 9.5.1. Asia Pacific: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.5. Antifungal Drugs Market - China
    • 9.5.5.1. China: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.6. Antifungal Drugs Market - India
    • 9.5.6.1. India: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.7. Antifungal Drugs Market - Malaysia
    • 9.5.7.1. Malaysia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.8. Antifungal Drugs Market - Japan
    • 9.5.8.1. Japan: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.9. Antifungal Drugs Market - Indonesia
    • 9.5.9.1. Indonesia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.10. Antifungal Drugs Market - South Korea
    • 9.5.10.1. South Korea: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.11. Antifungal Drugs Market - Australia
    • 9.5.11.1. Australia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.5.12. Antifungal Drugs Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• 9.6. Antifungal Drugs Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.6.5. Antifungal Drugs Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.6.6. Antifungal Drugs Market - UAE
    • 9.6.6.1. UAE: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.6.7. Antifungal Drugs Market - Israel
    • 9.6.7.1. Israel: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.6.8. Antifungal Drugs Market - South Africa
    • 9.6.8.1. South Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.6.9. Antifungal Drugs Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• 9.7. Antifungal Drugs Market - Latin America
  • 9.7.1. Latin America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.7.5. Antifungal Drugs Market - Mexico
    • 9.7.5.1. Mexico: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.7.6. Antifungal Drugs Market - Brazil
    • 9.7.6.1. Brazil: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.7.7. Antifungal Drugs Market - Argentina
    • 9.7.7.1. Argentina: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
  • 9.7.8. Antifungal Drugs Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbott
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Astellas Pharma, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Bayer AG
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Enzon Pharmaceuticals, Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Glenmark
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. GSK plc
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Merck & Co., Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Novartis AG
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Pfizer, Inc
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Sanofi
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development

List of Tables:

• Table 1 Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 2 Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 3 Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 4 Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 5 North America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 6 North America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 7 North America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 8 North America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 9 US: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 10 US: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 11 US: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 12 US: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 13 Canada: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 14 Canada: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 15 Canada: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 16 Canada: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 17 Europe: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 18 Europe: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 19 Europe: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 20 Europe: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 21 UK: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 22 UK: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 23 UK: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 24 UK: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 25 France: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 26 France: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 27 France: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 28 France: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 29 Germany: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 30 Germany: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 31 Germany: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 32 Germany: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 33 Italy: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 34 Italy: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 35 Italy: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 36 Italy: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 37 Spain: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 38 Spain: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 39 Spain: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 40 Spain: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 41 Netherlands: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 42 Netherlands: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 43 Netherlands: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 44 Netherlands: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 45 Russia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 46 Russia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 47 Russia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 48 Russia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 57 China: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 58 China: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 59 China: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 60 China: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 61 India: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 62 India: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 63 India: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 64 India: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 65 Malaysia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 66 Malaysia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 67 Malaysia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 68 Malaysia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 69 Japan: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 70 Japan: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 71 Japan: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 72 Japan: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 73 Indonesia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 74 Indonesia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 75 Indonesia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 76 Indonesia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 77 South Korea: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 78 South Korea: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 79 South Korea: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 80 South Korea: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 81 Australia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 82 Australia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 83 Australia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 84 Australia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 97 UAE: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 98 UAE: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 99 UAE: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 100 UAE: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 101 Israel: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 102 Israel: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 103 Israel: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 104 Israel: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 105 South Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 106 South Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 107 South Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 108 South Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 113 Latin America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 114 Latin America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 115 Latin America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 116 Latin America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 117 Mexico: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 118 Mexico: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 119 Mexico: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 120 Mexico: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 121 Brazil: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 122 Brazil: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 123 Brazil: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 124 Brazil: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 125 Argentina: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 126 Argentina: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 127 Argentina: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 128 Argentina: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Antifungal Drugs Market, By Drug Class, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Antifungal Drugs Market, By Indication, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Antifungal Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Antifungal Drugs Market, by Dosage Form, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Antifungal Drugs Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Drug Class
• Figure 7. Antifungal Drugs Market, By Drug Class, 2024 & 2034 (USD Billion)
• Figure 8. Market by Indication
• Figure 9. Antifungal Drugs Market, By Indication, 2024 & 2034 (USD Billion)
• Figure 10. Market by Distribution Channel
• Figure 11. Antifungal Drugs Market, by Distribution Channel, 2024 & 2034 (USD Billion)
• Figure 12. Market by Dosage Form
• Figure 13. Antifungal Drugs Market, by Dosage Form, 2024 & 2034 (USD Billion)